beryllium has been researched along with Astrocytoma, Grade IV in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belgaid, M; Khelifi, R; Taskaev, S; Zaidi, L | 1 |
| Abdul, AR; Gary, RK; Gorjala, P; Mudireddy, SR | 1 |
| Cairncross, JG; Gary, RK; Gorjala, P | 1 |
| Gary, RK; Gorjala, P | 1 |
| Akudugu, JM; Binder, A; Böhm, L; Giese, A; Serafin, A; Slabbert, J | 1 |
| Brassart, N; Chatel, M; Chauvel, P; Courdi, A; Grellier, P; Lonjon, M; Paquis, P; Pignol, JP | 1 |
| Harker, YD; Harmon, F; Kudchadker, RJ; Lee, CL; Zhou, XL | 1 |
7 other study(ies) available for beryllium and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Beam shaping assembly design of
Topics: Beryllium; Boron Neutron Capture Therapy; Brain Neoplasms; Computer Simulation; Equipment Design; Glioblastoma; Humans; Lithium; Phantoms, Imaging; Radioisotopes; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted | 2018 |
Beryllium is an inhibitor of cellular GSK-3β that is 1,000-fold more potent than lithium.
Topics: Beryllium; Cell Line; Cell Line, Tumor; Dose-Response Relationship, Drug; Fibroblasts; Fluorescence Resonance Energy Transfer; Glioblastoma; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Lithium Chloride; Phosphorylation; Phosphoserine; Protein Kinase Inhibitors; Real-Time Polymerase Chain Reaction; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2014 |
p53-dependent up-regulation of CDKN1A and down-regulation of CCNE2 in response to beryllium.
Topics: Antineoplastic Agents; Beryllium; Brain; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cytostatic Agents; Down-Regulation; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; RNA Interference; RNA, Messenger; RNA, Small Interfering; Tumor Suppressor Protein p53; Up-Regulation | 2016 |
Beryllium sulfate induces p21 CDKN1A expression and a senescence-like cell cycle arrest in susceptible cancer cell types.
Topics: Beryllium; beta-Galactosidase; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Genes, p53; Glioblastoma; Humans; Tumor Suppressor Protein p53 | 2010 |
Changes in G1-phase populations in human glioblastoma and neuroblastoma cell lines influence p66/Be neutron-induced micronucleus yield.
Topics: Beryllium; Cell Line, Tumor; Cell Survival; Flow Cytometry; G1 Phase; Glioblastoma; Humans; Linear Energy Transfer; Micronuclei, Chromosome-Defective; Micronucleus Tests; Neuroblastoma; Neutrons; Photons; Radiation Tolerance; Time Factors | 2004 |
Boron neutron capture enhancement (BNCE) of fast neutron irradiation for glioblastoma: increase of thermal neutron flux with heavy material collimation, a theoretical evaluation.
Topics: Beryllium; Boron Neutron Capture Therapy; Brain Neoplasms; Computer Simulation; Fast Neutrons; Glioblastoma; Models, Theoretical; Monte Carlo Method; Radiometry | 1999 |
A Monte Carlo dosimetry-based evaluation of the 7Li(p,n)7Be reaction near threshold for accelerator boron neutron capture therapy.
Topics: Beryllium; Biophysical Phenomena; Biophysics; Boron Neutron Capture Therapy; Glioblastoma; Humans; Lithium; Melanoma; Monte Carlo Method; Photons; Radioisotopes; Radiotherapy Planning, Computer-Assisted | 2000 |